CN103445141A - Lotus nut starch for protecting liver - Google Patents
Lotus nut starch for protecting liver Download PDFInfo
- Publication number
- CN103445141A CN103445141A CN2013103186934A CN201310318693A CN103445141A CN 103445141 A CN103445141 A CN 103445141A CN 2013103186934 A CN2013103186934 A CN 2013103186934A CN 201310318693 A CN201310318693 A CN 201310318693A CN 103445141 A CN103445141 A CN 103445141A
- Authority
- CN
- China
- Prior art keywords
- parts
- lotus nut
- liver
- nut starch
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 240000002853 Nelumbo nucifera Species 0.000 title claims abstract description 24
- 235000006508 Nelumbo nucifera Nutrition 0.000 title claims abstract description 24
- 235000006510 Nelumbo pentapetala Nutrition 0.000 title claims abstract description 24
- 210000004185 liver Anatomy 0.000 title claims abstract description 22
- 229920002472 Starch Polymers 0.000 title claims abstract description 21
- 235000019698 starch Nutrition 0.000 title claims abstract description 21
- 239000008107 starch Substances 0.000 title claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 12
- 235000000832 Ayote Nutrition 0.000 claims abstract description 9
- 235000008440 Crataegus cuneata Nutrition 0.000 claims abstract description 9
- 244000160089 Crataegus cuneata Species 0.000 claims abstract description 9
- 235000014283 Crataegus pinnatifida var major Nutrition 0.000 claims abstract description 9
- 240000004244 Cucurbita moschata Species 0.000 claims abstract description 9
- 235000009854 Cucurbita moschata Nutrition 0.000 claims abstract description 9
- 241000234435 Lilium Species 0.000 claims abstract description 9
- 240000004922 Vigna radiata Species 0.000 claims abstract description 9
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims abstract description 9
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims abstract description 9
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 9
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 9
- 235000008397 ginger Nutrition 0.000 claims abstract description 9
- 241001375196 Brandisia Species 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 240000006432 Carica papaya Species 0.000 claims abstract description 6
- 235000009467 Carica papaya Nutrition 0.000 claims abstract description 6
- 240000002234 Allium sativum Species 0.000 claims abstract description 4
- 235000004611 garlic Nutrition 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims description 7
- 240000006688 Telosma cordata Species 0.000 claims description 7
- 235000017352 Telosma cordata Nutrition 0.000 claims description 7
- 235000015136 pumpkin Nutrition 0.000 claims description 7
- 240000000249 Morus alba Species 0.000 claims description 6
- 235000008708 Morus alba Nutrition 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 239000002002 slurry Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 16
- 241000222336 Ganoderma Species 0.000 abstract description 14
- 210000004369 blood Anatomy 0.000 abstract description 3
- 239000008280 blood Substances 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 3
- 235000006264 Asimina triloba Nutrition 0.000 abstract description 2
- 230000036772 blood pressure Effects 0.000 abstract description 2
- 210000001835 viscera Anatomy 0.000 abstract description 2
- 235000003949 Cucurbita mixta Nutrition 0.000 abstract 2
- 241001047198 Scomberomorus semifasciatus Species 0.000 abstract 2
- 244000137773 Viola philippica Species 0.000 abstract 2
- 235000012467 brownies Nutrition 0.000 abstract 2
- 230000001914 calming effect Effects 0.000 abstract 2
- 241000219780 Pueraria Species 0.000 abstract 1
- 241001285524 Spermacoce stricta Species 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 description 8
- 150000004676 glycans Chemical class 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 5
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 230000007815 allergy Effects 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000032839 leukemia Diseases 0.000 description 3
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 230000002292 Radical scavenging effect Effects 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000036996 cardiovascular health Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 229940099472 immunoglobulin a Drugs 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 150000004804 polysaccharides Polymers 0.000 description 2
- 229940126532 prescription medicine Drugs 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- FYGDTMLNYKFZSV-WFYNLLPOSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,3s,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-WFYNLLPOSA-N 0.000 description 1
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- IHZXTIBMKNSJCJ-UHFFFAOYSA-N 3-{[(4-{[4-(dimethylamino)phenyl](4-{ethyl[(3-sulfophenyl)methyl]amino}phenyl)methylidene}cyclohexa-2,5-dien-1-ylidene)(ethyl)azaniumyl]methyl}benzene-1-sulfonate Chemical compound C=1C=C(C(=C2C=CC(C=C2)=[N+](C)C)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S(O)(=O)=O)=C1 IHZXTIBMKNSJCJ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 206010001513 AIDS related complex Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- RDMQPKIDHAFXKA-JNORPAGFSA-N Ganoderic Acid Am1 Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC(=O)C1=C2C(=O)C[C@]2(C)[C@@H]([C@@H](CC(=O)CC(C)C(O)=O)C)CC(=O)[C@]21C RDMQPKIDHAFXKA-JNORPAGFSA-N 0.000 description 1
- 229930182735 Ganoderic acid Natural products 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 206010019973 Herpes virus infection Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 241000175212 Herpesvirales Species 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102100037850 Interferon gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 208000029578 Muscle disease Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010036376 Postherpetic Neuralgia Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 206010044074 Torticollis Diseases 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 201000010918 connective tissue cancer Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 230000002079 cooperative effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000006680 metabolic alteration Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 230000037322 slow-wave sleep Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses lotus nut starch for protecting liver. The lotus nut starch comprises the following raw materials in parts by weight: 50-60 parts of ganoderma extract, 20-30 parts of lotus nut powder, 3-4 parts of papaya powder, 1-2 parts of viola yedoensis, 1-3 parts of ginger, 1-2 parts of garlic, 1-2 parts of lilium brownie, 2-3 parts of cushaw flower, 3-4 parts of mung bean, 3-5 parts of oat, 2-4 parts of Chinese hawthorn seed, 1-2 parts of hance brandisia herb, 1-2 parts of moutan bark, 2-3 parts of pueraria flower, 1-2 parts of rubiaceae borreria stricta, 3-4 parts of red dates, and 1-2 parts of folium mori. The lotus nut starch for protecting liver disclosed by the invention has a high health care value; the red dates have the effect of calming five internal organs and enriching the blood; the Chinese hawthorn seed has the roles of calming the liver and reducing blood pressure; the ginger, the pawpaw, the viola yedoensis, lotus seed, the lilium brownie, the cushaw flower, the mung bean and the like have good effects of protecting the liver. The lotus nut starch disclosed by the invention is free of toxic and side effects, and can promote physical fitness after being eaten for a long period of time.
Description
Technical field
The present invention relates generally to a kind of spore tablet, relates in particular to a kind of liver lotus nut starch that protects.
Background technology
Ganodenna Lucidum P.E has following effect: active anticancer
The cancer research of animal (for example: rat connective tissue cancer model) be presented at after utilizing Ganodenna Lucidum P.E treatment 50% tumour decline ratio is arranged.Ganodenna Lucidum P.E is used for the treatment of the cancer patient by Japanese part surgeon, and notices its significant antitumor and immunostimulation in numerous cases.The polysaccharide separated from the medicinal mushroom of glossy ganoderma and other has obtained patent in Japan and be used as immunomodulator in treatment of cancer.It is mixed with chemistry or radiotherapy and demonstrate the minimizing side effect, promotes the ability of result for the treatment of, and is used to promote rehabilitation.
The Ganodenna Lucidum P.E that studies show that of China has been strengthened the anti-tumor capacity of macrophage and T-cell.Ganodenna Lucidum P.E is known also has other immunoregulation effect and anti-oxidant properties.But zooscopy show equally glossy ganoderma polysaccharide part inducing leukemia cell Apoptosis (programmed death of cancer cell) and when utilizing the GL-B treatment, induced the leukaemia of 40%-45% Cell Differentiation to occur, prove its obvious treatment of cancer potentiality.These effects are main because GL-B induces the antitumor cell factor (signal agency) secretion of generation to rise, i.e. TNF-alpha and IFN-gamma, and also these two kinds of cell factors are to show cooperative effect suppressing that the leukaemia grows.In correlation test, the D-glucan polysaccharide of glossy ganoderma part demonstrates and produces theatrical tumour and fail to the research of rat malignant tumour the time.With it many animals used as test, selected colony to occur the decline fully of tumour after 5 weeks in injection beta-D glucan polysaccharide part.Y. Song waits the experiment carry out to report infected animal 90% tumor suppression ratio and 75% tumour decline with it.
Improve immune system: (bronchitis, asthma, nasal allergy disease, herpetic disease and HIV infect)
Numerous constituents of Ganodenna Lucidum P.E immunity-regulating system, wherein part is considered to have obvious antitumor properties.In the experiment that once comprises 2000 cases of China, utilize to concentrate after Garnoderma product is treated senile chronic bronchitis to demonstrate good reaction.This studies show that the Success Ratio that surpasses 60%.After the treatment of several months, obvious rising has appearred in the immunoglobulin A level in phlegm.Immunoglobulin A is the main immunoglobulin of finding in respiratory tract.Nasal allergy disease, in systemic lupus and rheumatoid arthritis, it generally there will be deficiency.The Ganodenna Lucidum P.E replenishers once showed and improved asthma and nasal allergy symptom.Two kinds of important component of Ganodenna Lucidum P.E, oleic acid and ring eight sulphur show the release that can suppress histamine, this may be for what being of value to the reason of asthma, a kind of special proteoglycan that is called as Glhw-02 in Ganodenna Lucidum P.E demonstrates the ntiviral characteristic that has effective antagonism 1 type and 2 type pure viruses under laboratory condition simultaneously.Once small-scale human experimentation shows that Ganodenna Lucidum P.E " dramatically " has reduced two postherpetic neuralgia patients' pain and having an intense pain of another two bit strip shape herpes infections (herpes zoster, because herpesviral causes) patient.
Under laboratory condition, in Ganodenna Lucidum P.E, multiple ganoderic acid and polysaccharide demonstration can be used as active anti-HIV material, and show under conservative dose and to reduce virus replication and reach 50% ability, after mixing with other east medicinal herbs, glossy ganoderma is used to now to AIDS related complex, the treatment of AIDS, and separately or+with the mixed treatment of other medicinal material chronic fatigue syndrome.
Cardiovascular health: (hypertension and minimizing platelet aggregation)
Twice controlled human experimentation shows that Ganodenna Lucidum P.E can reduce hypertension to extremely obvious degree (systolic pressure and cardiac enlargement are pressed), even for before those for the unresponsive patient of known antihypertensive drugs.Zoopery shows that Ganodenna Lucidum P.E reduces blood pressure by the central inhibitory action of right sympathetic activity, although this effect basically can not make decreased heart rate or cause sedation effect.Under laboratory environment, Ganodenna Lucidum P.E has slightly builds up effect to the less blood platelet of moderate, and this function in the future may be helpful to reducing the trouble risk of cardiovascular diseases.Its same demonstration can increase endurance, and blood flows into the brain flow and improves the oxygenation of cell.Similarly, it contributes to the energy of cellular level synthetic, its may improve cardiovascular health and in some culture for promoting memory and intelligence, comprising the successful utilization in Alzheimer's disease patient research.
Liver protection effect (protecting the liver characteristic)
Glossy ganoderma is used for chronic and treatment oxyhepatitis as prescription medicine in China.Multiple polysaccharide in glossy ganoderma has very strong anti-hepatotoxin characteristic, and the liver protection effect that it demonstrates under the chemical induction injury under laboratory environment, comprise the protective effect to high toxicity and lifetime killer carbon tetrachloride.
Support nervous system
Glossy ganoderma is recommended the insomnia for coming because of its " sleep promoting element " by the China and Japan herb doctor traditionally.Long-term use can cause the obvious promotion to slow wave sleep.Be used as prescription medicine for much psychiatry and neurology problem Chinese glossy ganoderma, comprising muscle disease, weak after anorexia and prolonged sickness.
Antiallergy/anti-inflammatory effect
In the seventies and the eighties, the anti-allergic effects of glossy ganoderma becomes the problem of the ongoing research of China and Japan.Studies show that Ganodenna Lucidum P.E obviously suppresses all four class allergy, comprises the positive role to asthma and contact dermatitis.In nineteen ninety, scientist in University of Texas's health sciences center of San Antonio finds that glossy ganoderma can be used for the treatment of Wry Neck effectively, shoulder is stiff, conjunctivitis (being lining in mocromembrane in eyes and eyelid is inflamed), bronchitis, rheumatism and in the situation that do not have apparent side effect to improve the immune system ability.
The anti-inflammatory ability part of glossy ganoderma may be because of its radical scavenging activity.Ganodenna Lucidum P.E obviously promotes the radical scavenging activity of blood, particularly resists harmful significantly hydroxy radical.The hydroxy radical removing ability of glossy ganoderma be so powerful so that Ganodenna Lucidum P.E be absorbed with metabolic alterations after its scavenging action still continue.
Anti-ageing
The classical Sheng Nong's herbal classic record of medicine in the time immemorial glossy ganoderma of China can effectively strengthen life energy (gas), increases thinking ability and prevents forgetful.It can recover body and intelligence, delays senility and makes the mankind can extending life.
Summary of the invention
The object of the invention just is to provide a kind of liver lotus nut starch that protects.
The present invention is achieved by the following technical solutions:
A kind of liver lotus nut starch that protects, it is comprised of the raw material of following weight parts:
Ganodenna Lucidum P.E 50-60, lotus nut starch 20-30, papaya powder 3-4, Chinese violet 1-2, ginger 1-3, garlic 1-2, lily 1-2, pumpkin flower 2-3, mung bean 3-4, oat 3-5, Chinese hawthorn seed 2-4, Hance Brandisia Herb 1-2, moutan bark 1-2, FI puerariae 2-3, Feng Huacao 1-2, red date 3-4, mulberry leaf 1-2.
A kind of preparation method who protects the liver lotus nut starch comprises the following steps:
(1) above-mentioned Chinese violet, lily, pumpkin flower, Hance Brandisia Herb, moutan bark, FI puerariae, Feng Huacao, mulberry leaf are mixed, extracting in water, filter merging filtrate;
(2) above-mentioned oat is added to 6-7 times of poach to water and seethe with excitement, add mung bean, ginger, Chinese hawthorn seed, red date, keep boiling 5-6 minute, cooling rear defibrination;
(3) filtrate that obtains and slurry are mixed, the rear filtration that stirs, concentrate, be dried to powder;
(4) powder after above-mentioned processing is mixed with each raw material of residue, stir, obtain the described liver lotus nut starch that protects.
Advantage of the present invention is:
The liver lotus nut starch that protects of the present invention has very high health care value, wherein red date has the effect that five viscera settling is enriched blood, Chinese hawthorn seed has the effect of flat liver step-down, ginger, pawpaw, Chinese violet, lotus seeds, lily, pumpkin flower, mung bean etc. all have and well protect liver function effect, powder of the present invention has no side effect, long-term edible can promote healthy.
The specific embodiment
Embodiment 1
A kind of liver lotus nut starch that protects, it is comprised of the raw material of following weight parts (kilogram):
Ganodenna Lucidum P.E 60, lotus nut starch 30, papaya powder 3, Chinese violet 2, ginger 3, garlic 1, lily 1, pumpkin spend 3, mung bean 4, oat 3, Chinese hawthorn seed 2, Hance Brandisia Herb 2, moutan bark 1, FI puerariae 3, Feng Huacao 2, red date 4, mulberry leaf 1.
A kind of preparation method who protects the liver lotus nut starch comprises the following steps:
(1) above-mentioned Chinese violet, lily, pumpkin flower, Hance Brandisia Herb, moutan bark, FI puerariae, Feng Huacao, mulberry leaf are mixed, extracting in water, filter merging filtrate;
(2) above-mentioned oat is added to 6 times of poach to water and seethe with excitement, add mung bean, ginger, Chinese hawthorn seed, red date, keep boiling 5 minutes, cooling rear defibrination;
(3) filtrate that obtains and slurry are mixed, the rear filtration that stirs, concentrate, be dried to powder;
(4) powder after above-mentioned processing is mixed with each raw material of residue, stir, obtain the described liver lotus nut starch that protects.
Claims (2)
1. one kind is protected the liver lotus nut starch, it is characterized in that what it was comprised of the raw material of following weight parts:
Ganodenna Lucidum P.E 50-60, lotus nut starch 20-30, papaya powder 3-4, Chinese violet 1-2, ginger 1-3, garlic 1-2, lily 1-2, pumpkin flower 2-3, mung bean 3-4, oat 3-5, Chinese hawthorn seed 2-4, Hance Brandisia Herb 1-2, moutan bark 1-2, FI puerariae 2-3, Feng Huacao 1-2, red date 3-4, mulberry leaf 1-2.
2. a preparation method who protects the liver lotus nut starch as claimed in claim 1 is characterized in that comprising the following steps:
(1) above-mentioned Chinese violet, lily, pumpkin flower, Hance Brandisia Herb, moutan bark, FI puerariae, Feng Huacao, mulberry leaf are mixed, extracting in water, filter merging filtrate;
(2) above-mentioned oat is added to 6-7 times of poach to water and seethe with excitement, add mung bean, ginger, Chinese hawthorn seed, red date, keep boiling 5-6 minute, cooling rear defibrination;
(3) filtrate that obtains and slurry are mixed, the rear filtration that stirs, concentrate, be dried to powder;
(4) powder after above-mentioned processing is mixed with each raw material of residue, stir, obtain the described liver lotus nut starch that protects.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310318693.4A CN103445141B (en) | 2013-07-26 | 2013-07-26 | One protects liver lotus nut starch |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310318693.4A CN103445141B (en) | 2013-07-26 | 2013-07-26 | One protects liver lotus nut starch |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103445141A true CN103445141A (en) | 2013-12-18 |
| CN103445141B CN103445141B (en) | 2016-02-10 |
Family
ID=49728319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310318693.4A Active CN103445141B (en) | 2013-07-26 | 2013-07-26 | One protects liver lotus nut starch |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103445141B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105341843A (en) * | 2015-11-04 | 2016-02-24 | 姚建成 | Preparation method of lotus nut starch with fragrance of flowers |
| CN106262148A (en) * | 2016-08-18 | 2017-01-04 | 杨帆 | A kind of heat-clearing and toxic substances removing powder of Radix Puerariae and preparation method thereof |
| CN106262508A (en) * | 2016-08-15 | 2017-01-04 | 邹健 | A kind of hepatoprotective lung moistening ginkgo powder and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102742880A (en) * | 2012-07-19 | 2012-10-24 | 湖南粒粒珍湘莲有限公司 | Preparation method of instant semen nelumbinis powder |
-
2013
- 2013-07-26 CN CN201310318693.4A patent/CN103445141B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102742880A (en) * | 2012-07-19 | 2012-10-24 | 湖南粒粒珍湘莲有限公司 | Preparation method of instant semen nelumbinis powder |
Non-Patent Citations (1)
| Title |
|---|
| 薛军 等: "挤压膨化对莲子粉糊化度及容积密度影响的研究", 《食品科学》, vol. 28, no. 5, 31 December 2007 (2007-12-31), pages 50 - 52 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105341843A (en) * | 2015-11-04 | 2016-02-24 | 姚建成 | Preparation method of lotus nut starch with fragrance of flowers |
| CN106262508A (en) * | 2016-08-15 | 2017-01-04 | 邹健 | A kind of hepatoprotective lung moistening ginkgo powder and preparation method thereof |
| CN106262148A (en) * | 2016-08-18 | 2017-01-04 | 杨帆 | A kind of heat-clearing and toxic substances removing powder of Radix Puerariae and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103445141B (en) | 2016-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103571704A (en) | Preparation method of agilawood health-care wine and agilawood wine thereof | |
| CN101401915A (en) | Chinese medicine formulation for treating cancer and preparation method thereof | |
| CN103445141B (en) | One protects liver lotus nut starch | |
| CN105878899A (en) | Eatable drug having function of assisting treatment of gastric mucosal lesion and preparation method thereof | |
| CN103251880B (en) | Pharmaceutical composition for treating tumor and preparation method thereof | |
| CN104606261B (en) | A kind of zeolite pharmaceutical composition and its production and use | |
| CN103446335A (en) | Conidial powder tablet with lucid ganoderma extract | |
| CN1973878A (en) | Medicine for treating children's stomachache and its prepn | |
| CN100334972C (en) | Body building health preparation and its producing method | |
| CN103381223A (en) | Medicament for treating epilepsy | |
| CN103446472A (en) | Anti-aging lucid ganoderma and fructus lycii powder | |
| CN106072569A (en) | The special dietary seafood of patient's immunocyte balance is regulated during a kind of chemicotherapy | |
| CN105055857B (en) | Treat the Chinese medicine preparation and preparation method thereof of Shelled Turtle Trionyx Sinensis stress disease | |
| CN108514634A (en) | Navel plaster | |
| CN104940843B (en) | A kind of Chinese medicine composition and preparation method thereof for treating gastric cancer | |
| CN103212050A (en) | Shenque powder | |
| CN104127532B (en) | The application of a kind of NAOXINTONG JIAONANG in preparation treatment oncosis medicine | |
| CN110721231B (en) | Traditional Chinese medicine composition for treating depression and preparation method thereof | |
| CN1413727A (en) | Composite medicine for radical curing AIDS | |
| CN104940702B (en) | Press down application of the dizzy peaceful particle in preparation treatment children suddenly hot infantile convulsion, tic of limbs drug | |
| CN106138314A (en) | A kind of Chinese medicine composition of body-building benefit brain and preparation method thereof | |
| CN1099282A (en) | Compound lotus plumule liquid and its preparation | |
| CN118217370A (en) | Compound taxol broad-spectrum anticancer Chinese medicinal preparation and its preparation method | |
| CN104173426A (en) | Traditional Chinese medicine composition with liver-protecting function, as well as preparation method and application thereof | |
| CN105079590A (en) | Traditional Chinese medicine for treating non-specific ulcerative colitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20200806 Address after: 213159 standard workshop of HUTANG science and Technology Industrial Park, HUTANG Town, Wujin District, Changzhou City, Jiangsu Province Patentee after: Changzhou Jinjian Biotechnology Co., Ltd Address before: 236000 Anhui Province, Fuyang city Yingquan District Wen town Patentee before: Yang Dejun |